Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment

Drug and Alcohol Dependence

Volumn 94, Issue 1-3, 2008, Pages 12-18

  Quaglio, Gianluca ^a,d   Lugoboni, Fabio ^a,d   Pattaro, Cristian ^b,d   Melara, Barbara ^a,d   Mezzelani, Paolo ^a,d   Des Jarlais, Don C ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b INSTITUTE FOR RENEWABLE ENERGY   (Italy)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d Group for Scientific Co operation Between Public Health Authority Centres for Drug Users   (Italy)

Author keywords

Buprenorphine; Erectile dysfunction; Methadone; Prevalence

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE;

ADOLESCENT; ARTICLE; BISEXUALITY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; ERECTILE DYSFUNCTION; FEMALE; HEROIN DEPENDENCE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RISK FACTOR; SOCIAL ASPECT; STRUCTURED INTERVIEW; UNIVARIATE ANALYSIS; ZUNG TEST;

ADOLESCENT; ADULT; BUPRENORPHINE; DEPRESSION; ERECTILE DYSFUNCTION; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; PREVALENCE; PSYCHOLOGY; QUESTIONNAIRES; SEXUAL PARTNERS; STATISTICS, NONPARAMETRIC;

EID: 39149083075     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.09.025     Document Type: Article

References (39)

1. Agresti A. Categorical Data Analysis. 2nd ed. (2002), John Wiley & Sons, Hoboken, New Jersey
2. Araujo A.B., Durante R., Feldman H.A., Goldstein I., and McKinlay J.B. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom. Med. 60 (1998) 458-465
3. Baldwin D.S. Sexual dysfunction associated with antidepressant drugs. Expert. Opin. Drug Saf. 5 (2004) 457-470
4. Bliesener N., Albrecht S., Schwager A., Weckbecker K., Lichtermann D., and Klingmüller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J. Clin. Endocrinol. Metab. 90 (2005) 203-206
5. Brown R., Balousek S., Mundt M., and Fleming M. Methadone maintenance and male sexual dysfunction. J. Addict. Dis. 24 (2005) 91-106
6. Brown R., Kraus C., Fleming M., and Reddy S. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad. Med. J. 80 (2004) 654-659
7. Cicero T.J., Meyer E.R., Miller B.T., and Bell R.D. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opioid agonists and antagonists. J. Pharmacol. Exp. Ther. 246 (1988) 14-20
8. Cushman P. Sexual behaviour in heroin addiction and methadone maintenance. Correlation with plasma luteinizing hormone. N.Y. State J. Med. 72 (1972) 1261-1265
9. Daniell H.W. Narcotic-induced hypogonadism during therapy for heroin addiction. J. Addict. Dis. 21 (2002) 47-53
10. Daniell H.W. Sex hormone deficiency in depressed patients receiving opioids. Arch. Intern. Med. 164 (2004) 804
11. El-Bassel N., Gilbert L., and Rajah V. The relationship between drug abuse and sexual performance among women on methadone. Heightening the risk of sexual intimate violence and HIV. Addict. Behav. 28 (2003) 1385-1393
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Selected issues 3. Buprenorphine: treatment, misuse and prescription practices. In: Annual Report 2005: the state of the drugs problem in Europe. Lisbon. Available from: http://issues05.emcdda.eu.int.
13. Hanbury R., Cohen M., and Stimmel B. Adequacy of sexual performance in men maintained on methadone. Am. J. Drug Alcohol Abuse 4 (1977) 13-20
14. Isidori A.M., Giannetta E., Gianfrilli D., Greco E.A., Bonifacio V., Aversa A., Isisidori A., Fabbri A., and Lenzi A. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin. Endocrinol. 63 (2005) 381-394
15. Jain P., Rademaker A.W., and McVary K.T. Testosterone supplementation for erectile dysfunction: results of a meta-analysis. J. Urol. 164 (2000) 371-375
16. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., and Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N. Engl. J. Med. 343 (2000) 1290-1297
17. Johnson S.D., Phelps D.L., and Cottler L.B. The association of sexual dysfunction and substance use among a community epidemiological study. Arch. Sex. Behav. 33 (2004) 55-63
18. Kokkevi A., and Stefanis C. Drug abuse and psychiatric comorbidity. Compr. Psychiatry 36 (1995) 329-337
19. Mendelson J.H., and Mello N.K. Plasma testosterone levels during chronic heroin use and protracted abstinence: study of Hong Kong addicts. NIDA Res. Monogr. 19 (1978) 142-148
20. Mendelson J.H., Mendelson J.E., and Patch V.D. Plasma testosterone levels in heroin addiction and during methadone maintenance. J. Pharmacol. Exp. Ther. 192 (1975) 211-217
21. Mendelson J.H., Meyer R.E., Ellingboe J., Mirin S.M., and McDougle M. Effects of heroin and methadone on plasma cortisol and testosterone. J. Pharmacol. Exp. Ther. 195 (1975) 296-302
22. National Institute on Drug Abuse (NIDA). Heroin Abuse and Addiction (2000), US Department of Health and Human Services, Rockville, MD (Publication no. 004165)
23. Negus S.S., Picker M.J., and Dykstra L.A. Kappa antagonist effects of buprenorphine in the rat drug discrimination procedure. NIDA Res. Monogr. 95 (1989) 518-519
24. Nurnberg H.G., Hensley P.L., Gelenberg A.J., Fava M., Lauriello J., and Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 289 (2003) 56-64
25. Parazzini F., Menchini Fabris F., Bortolotti A., Calabrò A., Chatenoud L., Colli E., Bandoni M., Lavezzari M., Turchi P., Sessa A., and Mirone V. Frequency and determinants of erectile dysfunction in Italy. Eur. Urol. 37 (2000) 43-49
26. Quaglio G.L., Talamini G., Lechi A., Venturini L., Lugoboni F., Des Jarlais D.C., Mezzelani P., and GICS. Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of seroconversion. Addiction 97 (2002) 985-992
27. Ragni G., De Lauretis L., Bestetti O., Sghedoni D., and Gambero V. Gonadal function in male heroin and methadone addicts. Int. J. Androl. 11 (1988) 93-100
28. R Development Core Team, 2006. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria.
29. Risen C.B. A guide to taking a sexual history. Psychiatr. Clin. N. Am. 18 (1995) 39-53
30. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kikpatrick J., and Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
31. Rosen R.C., Lane R., and Menza M. Effects of SSRIs on sexual function: a critical review. J. Clin. Psychopharmacol. 19 (1999) 67-85
32. Sachs L. Applied Statistics. A Handbook of Techniques. 2nd ed. (1984), Springer-Verlag, New York
33. Seidman S.N., and Roose S.P. The relationship between depression and erectile dysfunction. Curr. Psychiatry Rep. 2 (2000) 201-205
34. Spring Jr. W.D., Willenbring M.L., and Maddux T.L. Sexual dysfunction and psychological distress in methadone maintenance. Int. J. Addict. 27 (1992) 1325-1334
35. Strain E., Bigelow G., Liebson I., and Stitzer M. Moderate- vs. high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 281 (1999) 1000-1005
36. Swendsen J.D., and Merikangas K.R. The comorbidity of depression and substance use disorders. Clin. Psychol. Rev. 20 (2000) 173-189
37. Teusch L., Scherbaum N., Bohme H., Bender S., Eschmann-Mehl G., and Gastpar M. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opioid addicts. Pharmacopsychiatry 28 (1995) 84-92
38. Walsh S.L., and Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 70 (2003) S13-S27
39. Zung W.W.K. From art to science: the diagnosis and treatment of depression. Arch. Gen. Psychiatry 29 (1973) 328-337